Literature DB >> 9114202

Infectious diseases consultation: impact on outcomes for hospitalized patients and results of a preliminary study.

D C Classen1, J P Burke, R P Wenzel.   

Abstract

In the absence of detailed and specific data on outcomes, specialists are thought to contribute excessively to the cost of care. Infectious diseases physicians are at further risk of heavy utilization of medical resources because their patients often are those with serious complications or expensive underlying diseases (e.g., AIDS). By using readily available information in a sophisticated computer database, we examined the crude economic impact of an inpatient infectious diseases consultation and identified important matching variables for more refined analysis. The study was performed at LDS Hospital (Salt Lake City), a tertiary care facility with four full-time infectious diseases physicians. A total of 496 cases (patients who were seen by an infectious diseases consultant) were matched with 3,117 controls (patients who were not seen by an infectious diseases consultant). Matching was performed on the basis of age, sex, exact discharge diagnosis-related group, minimum length of hospital stay equal to the interval from admission to consultation for cases, and measures of the severity of illness (nursing acuity score and the number of secondary diagnoses). Cases had longer lengths of hospital stays, longer intensive care unit lengths of stays, and higher antibiotic costs than did matched controls, and if the consultation occurred in the last one-third of hospitalization, cases had shorter lengths of hospital stay and lower antibiotic costs than did controls.

Entities:  

Mesh:

Year:  1997        PMID: 9114202     DOI: 10.1093/clinids/24.3.468

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.

Authors:  S Diamantis; C Rioux; C Bonnal; É Farfour; E Papy; A Andremont; P Yeni; É Bouvet; J-C Lucet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-02       Impact factor: 3.267

Review 2.  Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.

Authors:  Siegbert Rieg; Marc Fabian Küpper
Journal:  Infection       Date:  2016-02-23       Impact factor: 3.553

3.  The value of specialist care-infectious disease specialist referrals-why and for whom? A retrospective cohort study in a French tertiary hospital.

Authors:  M Sasikumar; S Boyer; A Remacle-Bonnet; B Ventelou; P Brouqui
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-17       Impact factor: 3.267

4.  Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia.

Authors:  J O Robinson; S Pozzi-Langhi; M Phillips; J C Pearson; K J Christiansen; G W Coombs; R J Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-03       Impact factor: 3.267

5.  Vancomycin and home health care.

Authors:  Thomas G Fraser; Valentina Stosor; Qiong Wang; Anne Allen; Teresa R Zembower
Journal:  Emerg Infect Dis       Date:  2005-10       Impact factor: 6.883

6.  Appropriateness of gram-negative agent use at a tertiary care hospital in the setting of significant antimicrobial resistance.

Authors:  Neil M Vora; Christine J Kubin; E Yoko Furuya
Journal:  Open Forum Infect Dis       Date:  2015-02-19       Impact factor: 3.835

7.  The pattern and impact of infectious diseases consultation on antimicrobial prescription.

Authors:  Jaffar A Al-Tawfiq
Journal:  J Glob Infect Dis       Date:  2013-04

8.  The Value That Infectious Diseases Physicians Bring to the Healthcare System.

Authors:  Daniel P McQuillen; Ann T MacIntyre
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

9.  Dearth of infectious diseases physicians as the USA faces a global pandemic.

Authors:  Syed M Qasim Hussaini
Journal:  Lancet Infect Dis       Date:  2020-05-07       Impact factor: 25.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.